Penn Medicine at the 2026 American Heart Association’s Scientific Sessions
Penn Medicine faculty will present research on the latest advances in cardiovascular medicine at the 2026 AHA Scientific Sessions in Chicago.
University of Pennsylvania Perelman School of Medicine faculty will present research on the latest advances in cardiovascular medicine, science, and education at the 2026 American Heart Association’s Scientific Sessions, at McCormick Place Convention Center in Chicago, Illinois from November 6–9, 2026.
Expert interviews
To arrange interviews with any of these presenters or other Penn physicians who will be in attendance and can provide outside comment on other sessions, please call 267-600-4871 or email matthew.toal@pennmedicine.upenn.edu. All research results are embargoed until the time they are presented during the conference. All times listed are Central Standard Time. Please refer to the American Heart Association for embargo policies pertaining to presentations at the Scientific Sessions.
Penn’s Zoltan Arany to receive 2026 Distinguished Scientist Award
Zoltan Arany, MD, PhD, the Samuel Bellet Professor of Cardiology and chair of the Department of Physiology in the Perelman School of Medicine at the University of Pennsylvania, has been named an American Heart Association Distinguished Scientist for 2026, one of the organization’s highest scientific honors. The award recognizes researchers whose sustained and transformative contributions have advanced the understanding and treatment of cardiovascular disease.
Arany is internationally recognized for his pioneering work in cardiovascular metabolism, helping uncover how changes in the way the heart uses and produces energy contribute to conditions ranging from heart failure to peripartum cardiomyopathy. As director of Penn’s Cardiovascular Metabolism Program, his research has combined molecular biology, genetics, and human studies to reveal new insights into the metabolic mechanisms that drive heart disease and identify potential therapeutic targets.
Arany’s research has fundamentally changed researchers understanding of how metabolism influences cardiovascular health and disease. His work has earned election to the National Academy of Medicine and has resulted in more than 200 peer-reviewed publications in leading scientific journals. He will be recognized at the American Heart Association Scientific Sessions 2026 in Chicago.
Notable presentations by Penn Medicine faculty
Several Penn Medicine researchers and clinicians will participate in this year’s American Heart Association Scientific Sessions. The presentations highlighted below represent a selection of Penn’s contributions; for a comprehensive list of presenters and sessions, visit the AHA Scientific Sessions 2026 website.
Friday, November 6, 2026
10:15 – 10:30 AM
Presentation | Genomics in unsolved arrhythmia
Presenter: Andrew Landstrom, MD, PhD
1:00 – 1:05 PM
Presentation | Understanding Cardiovascular-Kidney-Metabolic Risk: Staging and Prevention
Presenter: Chiadi Ndumele, MD
5:15 – 5:24 PM
Presentation | Finding Your Mentors and Your Metrics: How to Launch in Cardio-Oncology
Presenter: Nicholas Wilcox, MD
Saturday, November 7, 2026
9:45- 10:00 AM
Presentation | Food Is Medicine to Reduce Cardiometabolic Risk: Emerging Evidence and Clinical Promise
Presenter: Kevin Volpp, MD, PhD
9:54 - 10:05 AM
Presentation | State of the Art II: Intermediate-Risk PE After HI-PEITHO and Storm PE: Have We Finally Beaten Anticoagulation Alone?
Presenter: Jay Giri, MD, MPH
2:00- 2:10 PM
Presentation A Randomized Controlled Trial of Spironolactone-Based Blood Pressure Management After Stroke
Presenter: Jordana Cohen, MD, MSCE
2:15 – 2:25 PM
Presentation | Genetic Lipidomic Analyses Reveal Specific Circulating Lipids as Potentially Causal Risk Factors for Aortic Stenosis in Contrast with Coronary Artery Disease
Presenter: Guoyi Yang, PhD
2:18 – 2:25 PM
Guidelines Presentation | Catheter-Based Therapies for PE: Patient Selection, Devices, and Guideline Integration
Presenter: Jay Giri, MD, MPH
Sunday, November 8, 2026
9:29 – 9:34 AM
Presentation | Growth Differentiation Factor-15 and Longitudinal Cardiac Function Following Breast Cancer Therapy
Presenter: Nicholas Wilcox, MD
3:15- 4:15 PM
Presentation | Genetic Reduction in Angiopoietin-Like Proteins 3 and 4 Exerts Distinct Effects on Cardiovascular Disease Risk Through Differential Enhancement of Lipase Activities
Presenter: Guoyi Yang, PhDMedia contact
Matt Toal
C: 267-600-4871
Matthew.Toal@pennmedicine.upenn.edu
For Media Queries & Requests (24/7): 215-662-2560